are semaglutide injections covered by insurance Does Cover Prescription Weight Loss Injectables? Starting July 2026, the temporary

Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea

Wegovy may help some women lose weight during menopause, particularly when combined with lifestyle and behaviour changes

Its effectiveness in regulating appetite and glucose levels makes it a valuable addition to our weight management strategies

Freeze-thaw rule If long-term storage is needed, freeze single-use aliquots rather than the same vial over and over